Europe PMC
open access
Myo-inositol as a spectroscopic marker of neuroinflammation in frontotemporal lobar degeneration
Background and Objectives Cost-effective and mechanistically-informative biomarkers are needed to advance novel therapeutics for dementia. We focus on neuroinflammation in disorders associated with frontotemporal lobar degeneration (FTLD). Commonly used assays include positron emission tom
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Seeing Beyond the Lesion: Disease Recognition from Reactive CNS Tissue#920043
- Frontiers in Clinical Drug Research - CNS and Neurological Disorders#1347395
- The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease#1212644
- Imaging biomarkers in functional neurological disorders.#988378
- Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy#1047018
Record · ID 1366627
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive